ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Review
Revised

COVID-19 in the Arab countries: Three-year review

[version 2; peer review: 3 approved with reservations]
PUBLISHED 09 May 2024
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Emerging Diseases and Outbreaks gateway.

Abstract

Background

Twenty-two Arab countries share a common language, history, and culture. Nevertheless, governmental policies, healthcare systems, and resources differ from one Arab country to another. We have been following Coronavirus (COVID-19) from the beginning in each Arab country. In the present study, we aimed to assess the prevalence of COVID-19 in the Arab world and to compare these findings with other significantly affected countries.

Methods

Websites of the World Health Organization, World COVID-vaccinations tracker, Worldometer, and Ministries of Health were used to extract COVID-19 data in all Arab countries between the period January 2020 to December 2022.

Results

All Arab countries had 14,218,042 total confirmed COVID-19 cases, 13,384,924 total recovered cases and 173,544 total related deaths. The trend demonstrated that the third quarter of 2021 recorded the highest death toll and the first quarter of 2022 recorded the highest number of confirmed and recovered cases. Compared to the top 15 affected countries, the Arab world ranked last as it had the lowest overall incidence per million population (PMP) of 31,609. The data on total deaths PMP showed that India had the lowest number of deaths with only 377 cases followed by the Arab world with 386 cases.

Conclusions

Although the number of confirmed, death, and subsequently recovered cases of COVID-19 have greatly reduced in the last quarter of 2022 in most Arab countries, many Arab countries still need to re-campaign about COVID-19 vaccines and raise awareness programs about boosters. COVID-19 has had a relatively smaller impact on Arab countries than on other countries that have been significantly affected.

Keywords

Arab countries, confirmed, coronavirus, recovered, COVID-19, COVID-19 vaccines, death

Revised Amendments from Version 1

More information about the public opinions of vaccine safety and efficacy.

The results of vaccination campaigns in some Arab countries have been added.

Another study limitation has been added.

See the authors' detailed response to the review by Muhammad Nauman Zahid
See the authors' detailed response to the review by Ahmad A. Alrasheedi
See the authors' detailed response to the review by Yasser Amer

Introduction

On March 11, 2020, the World Health Organization (WHO) declared Coronavirus (COVID-19) as a pandemic. COVID-19, which is caused by severe acute respiratory syndrome-coronavirus (SARS-CoV-2), is a highly contagious virus.1 In the last three years, COVID-19 has infected and killed millions of people around the world, including those in Arab countries. When COVID-19 started in the first period of 2020 and the PCR tests were not available, fever, dry cough, sore throat, headache, fatigue, and breathlessness were the common symptoms for COVID-19 patients. However, many people with COVID-19 remain asymptomatic but can transmit SARS-CoV-2 to others.2,3

In the past, vaccines have saved lives, avoided illness and infection, and been evaluated as effective health interventions.4 In fact, WHO has shown that vaccines are safer than treatment.5 COVID-19 vaccines reduce the risk of illness, hospitalization, and death from COVID-19. A study showed that the mean percentage of death with one dose was 11.55% compared to 4.31% after the second dose of any type of approved vaccine.6 Globally, it has been estimated that about eight billion doses of the COVID-19 vaccine have been distributed to reduce the rate of COVID-19.7 Comprehensively, the COVID-19 vaccination saved approximately 20 million lives during its first year of distribution.8 As of January 1, 2023, more than 5.51 billion people worldwide have received a dose of a COVID-19 vaccine, which corresponds to approximately 71% of the world population, and fully vaccinated about 66%.9

A recent study in Qatar concluded that deaths attributable to SARS-CoV-2 vaccination are extremely rare.10 They reported that the death rate among the vaccinated persons with a high probability of relationship to SARS-CoV-2 vaccination was 0.34 per 100,000 vaccine recipients, while the death rate among the vaccinated persons with either high or intermediate probability of relationship to SARS-CoV-2 vaccination was 0.98 per 100,000. In line with this study, the United States Centers for Disease Control and Prevention identified only nine deaths from 14,980 reports of death among more than 589 million vaccine doses between December 14, 2020, and June 6, 2022.11

On the other hand, WHO has identified many different variants of the coronavirus SARS-CoV-2 including Alpha, Beta, Omicron, Gamma, Delta, Eta, Iota, Kappa, Zeta, and Mu. On 26 November 2021, WHO declared the Omicron variant, known as lineage B.1.1.529, a variant of concern.12 It was first identified in Botswana and South Africa.13Although the Omicron variant (B.1.1.529) causes less severe symptoms, it is more contagious and spreads faster than any previous variant. Many studies reported that this variant causes reinfection, and may escape the immune system’s defenses, and two doses of vaccination appeared to be less effective.1416 However, some studies show that boosters can provide protection against Omicron infection.1719 Unfortunately, these variants and probably others will continue to emerge as long as the coronavirus SARS-CoV-2 remains.

The development of vaccines is usually a lengthy and complex process. However, in order to stop the transmission of COVID-19, vaccine development has been accelerated.20,21 Despite unequal vaccine distribution, vaccine hesitancy, and waning immunity, billions of vaccine doses have been administered worldwide. One of the major causes of vaccine hesitancy and delay in vaccination is the concern about adverse effects.22 As of December 29, 2022, WHO approved 11 COVID-19 vaccines including Sinopharm, Sinovac, Bharat Biotech, Moderna, Pfizer/BioNTech, Oxford/AstraZeneca, Serum Institute of India, Janssen/Johnson & Johnson, Novavax, Serum Institute of India, and CanSino.23

The Arab world contains 22 countries, distributed 12 in Asia and 10 in Africa. Language, history, traditions, and culture are shared by Arab countries.24 However, the healthcare systems and availability of resources differ from one Arab country to another. Previously, we published two review papers. The first was a 5-month COVID-19 data in all Arab countries from January 1, 2020, to May 31, 2020, and concluded that most Arab countries took some serious early steps to minimize the outbreak of COVID-19.25 The second one was a one-year from February 2020 to February 2021, and we concluded that among the Arab countries, Qatar, Bahrain, and Lebanon showed the highest number of recovered, confirmed, and deaths per million population, respectively. The number of confirmed and death cases among Arab countries triggers significant worries about morbidity and mortality related to COVID-19, respectively.26 We have been following COVID-19 from the beginning in each Arab country. In the present study, we aimed to assess further the prevalence of COVID-19 in the Arab world from January 2020 to December 2022 and to compare these findings with other significantly affected countries.

Methods

We used the WHO, World COVID-vaccinations tracker, Worldometer, and Ministries of Health official websites to search for COVID-19 data in Algeria, Bahrain, Comoros, Djibouti, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Palestine, Qatar, Saudi Arabia (SA), Somalia, Sudan, Syria, Tunisia, United Arab Emirates (UAE), and Yemen. The period covered was from January 2020 to December 2022. The inclusion criterion was official information about clinically diagnosed COVID-19 in English or Arabic. The exclusion criterion was unofficial information regarding COVID-19 in all Arab countries, unspecified date and location of information, or suspicion of duplicate information. The data were collected monthly and verified with the data in the Worldometer. The following information was collected from each Arab country: total population, median age, number of monthly confirmed, death, and recovered cases, the total number of COVID-19 tests, and COVID-19 vaccine rates (first and second). The data for the topmost 15 affected countries were extracted from the Worldometer at the same time as the data for the Arab countries. Ethical approval and written informed consent were not required for this type of study. Data were analyzed using the IBM SPSS Statistics (RRID:SCR_016479) software version 25 (SPSS Inc., Chicago, IL, USA). Results are presented as numbers, percentages, and means.

Results

By January 01, 2023, the total Arab population who live in Arab countries was 449,809,846. Egypt recorded the highest population among all Arab countries, followed by Sudan, and Algeria with 106,156,692, 45,992,020, and 45,350,148, respectively. The highest median age was seen in UAE, followed by Qatar, and Bahrain with 38.4, 33.7, and 32.3 years, respectively. Whereas the lowest median age was seen in Sudan at 18.3 years. All Arab countries utilized real-time polymerase chain reaction (RT-PCR) as the testing method for SARS-CoV-2. The total number of COVID-19 tests in all Arab countries was 362,542,626. UAE (19,632,329) recorded then the highest number of tests per million population (PMP), followed by Bahrain (5,960,320), and then Oman (4,695,724). The people in Qatar and the United Arab Emirates have received two doses of the COVID-19 vaccine equally to about 99% whereas those in Yemen received only 3% for both doses (Table 1).

Table 1. Features of the Arab countries related to COVID-19 from January 2020 to December 2022.

CountriesPopulationMedian age, yearsTotal testsTests PMPOne dose of COVID-19 vaccine in %Two doses of COVID-19 vaccine in %
Egypt106,156,69223.93,693,36734,7925440
Sudan45,992,02018.3562,94112,2402519
Algeria45,350,14828.9230,8615,0911815
Iraq42,164,9452019,448,292461,2432920
Morocco37,772,75629.312,856,284340,3596964
SA35,844,90930.844,940,5641,253,7507974
Yemen31,154,86719.8329,59210,57933
Syria19,364,80924.3146,2697,5531913
Somalia16,841,79518.5400,46623,7784941
Tunisia12,046,65631.64,983,949413,7216255
Lebanon10,300,86930.54,795,578717,3804035
UAE10,081,78538.4197,928,92219,632,3299999
Libya7,040,74528.92,483,446352,7253418
Jordan6,684,84922.517,201,8851,669,9454845
Palestine5,345,54121.13,078,533575,9074338
Oman5,323,99325.625,000,0004,695,7246561
Kuwait4,380,32629.38,447,3001,928,4648279
Qatar2,979,91533.74,065,3691,364,2579999
Bahrain1,783,98332.310,633,1105,960,3207675
Mauritania1,274,72720.51,009,957206,0304634
Djibouti1,016,09723.9305,941301,0943331
Comoros907,41919.9NANA5247
Total/Average449,809,84626362,542,6261,903,204

The total number of COVID-19 cases in all Arab countries was 14,218,042 and of those, 173,544 (1.2 %) were deceased and 13,384,924 (94%) were recovered. Jordan, Qatar, Kuwait, Palestine, and Lebanon recorded the highest number of reported cases PMP with 261,404, 164,032, 151,138, 131,568, and 118,957, respectively. Yemen recorded only 383 cases PMP. Based on the evaluation of three years from January 2020 to December 2022, the trend showed that the first quarter of 2022 had the highest number of confirmed COVID-19 cases in all Arab countries with 3,235,665 cases. In the same quarter period, 11 Arab countries scored their highest number of COVID-19 confirmed cases (Table 2).

Table 2. The trend of quarterly COVID-19 confirmed cases in all Arab countries from January 2020 to December 2022.

CountriesQ1-20Q2-20Q3-20Q4-20Q1-21Q2-21Q3-21Q4-21Q1-22Q2-22Q3-22Q4-22TotalPMP
Jordan26886410,693282,669323,565133,34573,293238,708630,8114,36848,86601,747,450261,404
Qatar78195,30729,67218,07436,13042,10714,57213,885110,44420,96269,13837,730488,802164,032
Kuwait28945,90658,98945,40481,619124,47454,5395,455213,13715,01212,9854,227662,036151,138
Palestine1172,49037,47198,105135,04869,89893,87933,514185,5193,81242,915536703,304131,568
Lebanon4701,30837,856141,869286,89776,46680,579102,48536457919,690103,7269,4441,225,369118,957
UAE66947,99845,523112,561253,623170,330103,08525,94512937254,50081,70219,5061,044,814103,633
Tunisia39377916,233119,811118,092164,795287,88019,86030804116,29693,5061,8851,147,57195,260
Oman19239,87858,51530,28230,351109,32734,5111,720818082,3857,265656396,89074,547
Libya881633,70165,41060,04533,494147,61747,6431130044004,856148507,14272,029
Iraq63048,479313,872232,310255,633494,980665,73082,10622616828,754111,3206,6272,466,60958,499
Mauritania64,1433,3256,1684,2052,96115,3065,753168021,1453,00960263,42549,755
Morocco60211,783108,798316,14959,34434,685403,46730,59219779453,69548,0526,6341,271,59533,664
SA1563189,260143,78228,13627,26697,58559,6058,10219457844,28222,23310,615827,00723,071
Djibouti314,6517344082,3563,4221,27978719171050015,69015,441
Comoros03031712912,9392392042,5411398143715118,9829,898
Algeria71613,19137,30648,09817,99322,32264,03115,161468534164,589552271,2285,980
Egypt71167,60034,76833,56566,19978,43924,74880,32811890610,38100515,6454,857
Syria102693,9217,2347,6056,4769,40515,35854282211,38016957,4762,968
Somalia52,9196641,1266,7853,4475,0343,55228783934118627,3001,620
Sudan79,2514,38211,8604,6116,5471,6708,1901543766966140163,6861,384
Bahrain56725,98044,10621,81151,770121,3829,2307,00526911170,38354,91617,811694,072389
Yemen01,158876682,4292,3892,2199871680181111411,949383
Total8035614,3331025,3581621,4091834,5051,799,1102,151,883749,6773235665347,901712,012118,15414,218,042

Deaths PMP were dominant in Tunisia, Jordan, Palestine, Lebanon, and Libya with 2,430, 2,116, 1,073, 1,052, and 914, respectively. The trend demonstrated that the third quarter of 2021 had the highest number of deaths in all Arab countries with 31,275 cases. In the same quarter period, five countries had the highest number of COVID-19-related deaths (Table 3).

Table 3. The trend of quarterly COVID-19 death cases in all Arab countries from January 2020 to December 2022.

CountriesQ1-20Q2-20Q3-20Q4-20Q1-21Q2-21Q3-21Q4-21Q1-22Q2-22Q3-22Q4-22TotalPMP
Tunisia10401964,3744,2236,1169,9626552,7473685583529,2842,430
Jordan54683,7733,0902,8109771,9261,39520691214,1492,116
Palestine173031,0891,50193257952272156885,7361,073
Lebanon12223631,2214,6161,6174907781,18715925311910,8371,052
Libya0245278931,2365131,4711,04670911706,437914
Bahrain483164101169831375752128181,536861
Oman11757595641791,4119742013610004,229794
Mauritania01263518110740288931121122997782
Iraq461,8977,2383,6321,5102,8635,2061,7661,009741332725,401602
Kuwait035425632437964547719871572,554583
Morocco361891,9275,2031,4704715,0195361,209491691616,294431
SA101,6393,1191,4554461,1508971611701641461639,520265
UAE630910425082831428667138142932,348233
Egypt462,9072,9611,6624,4654,1281,2304,3692,6491960024,613232
Qatar21111013146299161357233684229
Djibouti05470108414200000189186
Comoros070213701103010161177
Syria27191511563602389632243102603,176164
Algeria588548071,0323456202,1034655901426,881152
Sudan25702647255026911504271,5764410334,994108
Somalia090931407238336222170291,36181
Yemen0312275232964553732501597942,16369
Total2419,78119,67427,07726,52526,83031,27514,00214,9891,1571,532461173,544

Bahrain, Jordan, Kuwait, Qatar, and Palestine showed the highest number of recovered cases PMP with 307,175, 258,944, 147,542, 134,455, and 131,528, respectively. The trend showed that the first quarter of 2022 had the highest number of recovered cases in all Arab countries with 3,261,712 cases. In the same quarter period, 10 countries had the highest number of recovered cases (Table 4).

Table 4. The trend of quarterly COVID-19 recovered cases in all Arab countries from January 2020 to December 2022.

CountriesQ1-20Q2-20Q3-20Q4-20Q1-21Q2-21Q3-21Q4-21Q1-22Q2-22Q3-22Q4-22TotalPMP
BahrainNA14,685NANA20,226125,9725,9334,065267,76865,99543,351NA547,995307,175
Jordan268563,744265,925249,947214,59666,432217,370660,0454,80547,26101,731,007258,944
Kuwait7336,95759,75649,83170,573118,64070,9783,098213,36111,22911,788NA646,284147,542
Qatar6281,50241,13518,72322,69955,67814,96310,480114,06017,28024,083NA400,665134,455
Palestine1860740,60391,590112,10691,95271,37953,346187,6213,62237,82112,426703,091131,528
Lebanon351,14815,927151,201202,376161,85063,53163,380402,78325,356001,087,587105,582
UAE6137,50546,154100,718260,913166,087114,80416,520122,60758,18780,88222,9271,027,365101,903
Tunisia11,0281,512104,639110,748136,513323,18418,861312,3480001,008,83483,744
Oman3423,39164,70433,36222,48088,01562,9711,28482,5581,730NANA380,52971,474
Libya020919,15252,74675,75730,52382,498115,393113,7749219,537151500,66171,109
Iraq15224,608267,437245,644226,255481,432680,125139,317217,99725,792124,9457,4362,441,14057,895
Mauritania21,6205,4694,2895,7132,69714,9764,46418,4566203,48663162,42348,969
Morocco248,81591,414307,25176,20733,865391,32232,110206,24928,10573,1926,2941,254,84833,221
SA165130,601187,16534,65024,230113,42468,1855,173175,19339,66223,5096,419808,37622,552
Djibouti24,5228203848104,9057581,1832,006370015,42715,182
Comoros02002533632,7202292018323,121143725148,8199,718
Egypt15718,30377,63416,45242,47056,36846,86862,880115,3795,67100442,1824,165
Algeria469,85126,06531,16514,50515,45742,43510,78428,0501793,776335182,6484,027
Syria01059984,1937,5598,9702,2028,48714,8165,4281,34124954,3482,806
Sudan04,0142,7506,77210,6786,3021,5996,5991,615016,96188958,1791,265
Somalia09322,0146661,2492,3852,2773,42523400013,182782
Yemen04887981082882,3861,5911,3631,67151312359,334299
Total858401,947955,5041,520,6721,560,5091,918,2462,129,212780,4143,261,712295,146502,42858,27613,384,924

In comparison to the topmost 15 affected countries, the Arab world ranked 16 as it had the lowest overall incidence PMP of 31,609. The data on total deaths PMP showed that India had the lowest number of deaths with only 377 cases followed by the Arab world with 386 cases. The United States recorded the highest number of deaths with 3,339 cases. In terms of the total number of tests for SARS-CoV-2, Arab countries ranked eleventh with 805,990 tests PMP. The highest number of tests PMP was conducted by Spain (10,082,298) and the lowest was by Brazil (296,146). Arab countries showed the youngest median age followed by India with 28.7 years as its median age. Conversely, Japan had the oldest median age of 48.6 years, however, it had fewer COVID-19 deaths per million populations with 456 cases. It is worth mentioning that six of the top 15 affected countries are from Europe. France was the worst country (after South Korea) as it recorded 599,471 cases PMP and ranked first. Other parameters, which include total tests and population, are also compared (Table 5).

Table 5. Comparison of COVID-19 prevalence between the Arab world and the top 15 affected countries from January 2020 to December 2022.

CountryTotal Confirmed casesTotal Death casesTotal Cured casesConfirmed cases PMPDeaths PMPTotal TestsTests PMPPopulationMedian Age, years
1.France39,316,017161,96238,342,881599,4712,470271,490,1884,139,54765,584,51841.7
2.S. Korea29,116,80032,21927,893,416567,24862815,804,065307,89251,329,89943.2
3.Germany37,369,865161,46536,615,400445,4971,925122,332,3841,458,35983,883,59647.8
4.Australia11,131,70717,05210,979,282427,01365478,835,0483,024,11626,068,79244.5
5.Italy25,143,705184,64224,541,402417,2343,064262,558,7414,356,89860,262,77046.5
6.UK24,135,084198,93723,844,243352,3482,904522,526,4767,628,35768,497,90740.6
7.USA102,513,6901,117,98399,513,507306,1893,3391,152,003,6313,440,817334,805,26938.5
8.Spain13,684,258117,09513,486,683292,9052,506471,036,32810,082,29846,719,14243.9
9.Japan29,212,53557,26621,105,754232,61245686,237,109686,684125,584,83848.6
10.Argentina9,891,139130,1249,609,732214,9772,82835,716,069776,26446,010,23432.4
11.Turkey17,042,722101,492N/A199,1861,186162,743,3691,902,05285,561,97632.2
12.Brazil36,354,255693,94134,938,186168,8123,22263,776,166296,146215,353,59333.2
13.Russia21,798,509393,71221,207,802149,5042,700273,400,0001,875,095145,805,94740.3
14.Vietnam11,525,23143,18610,611,275116,47143685,826,548867,34298,953,54131.9
15.India44,679,564530,70244,144,02931,764377910,365,101647,1951,406,631,77628.7
16.Arab World14,218,042173,54413,384,92431,609386362,542,626805,990449,809,84626.0

Discussion

The present study aimed to assess the prevalence and the impact of the COVID-19 pandemic in 22 Arab countries and compare them with other significantly affected countries from January 2020 to December 2022. COVID-19 confirmed cases increased exponentially in the first quarter of 2021 due to the New Year season with Jordan demonstrating the highest number of cases followed by Lebanon. A dramatic increase in COVID-19 confirmed cases occurred in the third quarter of 2021 due to the emergence of the Delta variant,27 which peaked in Iraq with a total number of 665,730. Another reason for the spike increase is the slow uptake of the vaccine in many countries.28 For example, only 20% of the population in Iraq had received single/double doses of the COVID-19 vaccine. In addition, people in several countries, such as Iraq, refused to take the vaccine, which in turn, might have played a role in accelerating the number of COVID-19 confirmed cases.29 Furthermore, the re-opening of schools and businesses, people returning from holidays and social mixing subsidized the escalation in the COVID-19 confirmed cases at the end of summer and the start of winter of 2021.27 The situation was further aggravated by the economic disturbance in some of these countries hence, they had a compound crisis; COVID-19 and economic disruption.30

Preventive measures taken by countries during the pandemic affected the spread of the COVID-19 virus. During the first, second, and third quarters of 2020, the pandemic was under control in most Arab countries due to the implementation of extreme precautionary measures. The major measures include land, sea, and air route closure, nighttime or all-day curfew and lockdown, school and universities closure, worship places closure, prohibition of gatherings, closure of shops, malls, beaches, public parks, and gardens, cancellation of all cultural and sports events, festivals, seminars, and scientific meetings, and suspension of work in all government and private sectors.3133A study conducted in Saudi Arabia showed that preventive measures had an enormous effect in reducing the number of expected confirmed cases of COVID-19 from 437,096 cases to an observed number of 28,656 at the beginning of the second quarter of 2020.34 Because of the economic crisis in some countries like Jordan, some of these measures were diminished in the fourth quarter of 2020, leading to an increase in COVID-19 cases.35

The first quarter of 2022 was a shockwave as it was recorded with the highest-ever number of COVID-19 confirmed cases with 3,235,665 peaked by Jordan with a total number of 630,811. The potential reason for the spike is the occurrence of the Omicron variant that had affected the death rate and increased hospitalization.36 On the other hand, the pandemic had intense consequences on the economy of many countries. Therefore, to revive the economy, different approaches were taken such as the period of isolation of the infected people was reduced and guidelines on PCR testing of suspected COVID-19 cases became more restrictive.35 Subsequently, there was a dramatic decrease in the confirmed cases in the second quarter of 2022, which continued to decline until the end of the year. Both the third-fourth quarters of 2021 and 2022 demonstrated a similar wave but with a lesser rate of confirmed COVID-19 cases in 2022. This could be due to the higher vaccine coverage in that year emphasizing the importance and the impact of vaccination intake.37 Despite the full vaccination coverage in Qatar (99%), Qatar was reported with the highest number of confirmed cases of COVID-19 in the fourth quarter of 2022 with a total number of 37,730. The conceivable reason could be that Qatar was hosting the World Cup 2022 with no COVID-19 restrictive measures required to enter the country, which had strikingly increased the social gathering and thus, increased COVID-19 confirmed rates.38

Among Arab countries, such as the Gulf Cooperation Council (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and UAE) and Morocco, with over 60% of their population fully vaccinated, showed a sharp decrease in the death rate PMP in the last quarter of 2021 (Table 3). However, the first quarter of 2022 retained a death peak, which disappeared by the second quarter of the same year, probably because of the fast-spreading Omicron variant wave. Countries like Yemen, Syria, Iraq, and Sudan showed a low percentage of vaccination, a low number of tests, and surprisingly low deaths PMP (Tables 1 and 3). Political instability and a weak healthcare system that depends on outside humanitarian aid could be attributed to a lack of regular testing and continued poor documentation of COVID-19 status.25

Jordan, as an example of an Asian country, experienced the first wave of viral spread during the fourth quarter of 2020, lasted until January 2021, and resulted in a great increase in accumulative confirmed and death cases. Before the first wave started, epidemiological status was under control, but by early September 2020 some restrictions were removed, e.g., land boundaries were opened for export/import goods from neighboring countries, universities opened doors for registration, and people started to take the crisis less seriously.35 The second wave in Jordan was led by the fast-spreading UK variant that started in January 2021 continued until May 2021 and peaked in March 2021. The Indian Delta strain spread in Jordan during the second quarter and beginning of the third quarter of 2021, but the epidemiological data did not show any peak due to vaccination or naturally acquired immunity.35 The third and fourth waves, from October 2021 until January 2022 and January 2022 to March 2022, respectively, started as the government halted many preventive measures due to economic stress. Both waves were led by the Omicron variant.35

Tunisia, as an example of an African country, started to record positive cases in early March 2020, however by June 2020, the government could control the situation by applying preventive measures, which resulted in zero cases between 4th and 12th June. In July 2020, borders opened and clear slackening in sticking with preventive measures by people resulted in the second wave, which affected the country. March 2021 was the start of the third wave in Tunisia, which was highlighted by severe cases and a high transmission rate, caused by the Alpha variant after the fourth wave, which was led by the Delta variant that occurred in May 2021. During this period, Tunisia got a high rate of deaths PMP (Table 3). The Omicron variant of concern was the cause of the fifth wave by the end of 2021, so the country experienced another peak of death during the first quarter of 2022. These waves attributed to a large number of deaths. Tunisia has the highest number of deaths PMP among Arab countries. The economic crisis in addition to political problems made it difficult for the government to control COVID-19 and this in turn, resulted in the delay of the introduction and dissemination of COVID-19 vaccines.39

Studying the trend of recovered cases is a useful indication of the health status and the health system in these countries. It is also a good tool to be used in terms of applying certain restrictions such as the duration of lockdown. From January 2020 to December 2022, all Arab countries showed various numbers of recovered cases of COVID-19. Such variation depended initially on the number of infected cases and on a broader scope, the severity of infection, treatment, patient immunity, vaccination, and other political and health factors.37 Although some data were missing on the number of recovered cases for some countries, Bahrain, followed by Jordan, Kuwait, and Qatar showed the highest among all Arab countries. Whereas, Syria, Sudan, Somalia, and Yemen showed the lowest number of recovered cases, which may be explained by the unstable political status and subsequently the weakness of the healthcare system. Over time and based on the registered cases, the trend of recovered cases started at a low, reached a high peak, and eventually declined. This trend is common in such pandemics and the mode of spreading such infection had been observed in the previous pandemic.40 The bell-shaped trend in certain countries such as Palestine, given all collected data, are accurate, and helped tremendously in managing the pandemic crisis in terms of lockdown, financial and social impact, and predicting the coming waves of the mutant viruses.

The effect of a complete vaccination regimen on the recovered cases was not consistent among Arab countries. As mentioned previously, Qatar had the highest percentage of the vaccinated population but was not the top-rated country in the recovered cases. Such observation does not exclude the importance of vaccination effect on these cases rather than additional factors that might have contributed to this outcome.

A recent study showed the effectiveness of the vaccine in preventing SARS-CoV-2 infection and its symptoms. In addition to other mitigation strategies, vaccine campaigns could have a great impact on the number of confirmed and recovered cases.41 Although quarantine was one of the most important measures in controlling the spread of the epidemic,42 such a theory changed once the right vaccine was used. Quarantine controls the disease by the large fraction of pre-symptomatic and asymptomatic transmission, unlike the vaccine that eliminates the virus and reduces its symptoms in many cases.

During the recent pandemic, vaccination campaigns have proven their effectiveness to control the disease and reduce the severity of its symptoms. Certain tactics were used to enhance public awareness and acceptance of vaccine during these campaigns. One of the most effective tactics was to address public opinions of vaccine safety and efficacy by disseminating accurate information through authorized channels. This information was in different languages to reach out all in the community. Community engagement and healthcare guidance were also helpful. During the vaccination process, the uptake of vaccine was enhanced by removing any obstacle that might delay such a process. For example, setting up vaccination centers in different locations with an easy access and quick appointment. These centers had big area to accommodate more people at each time. Community outreach existed for those who could not go to these centers.43 Unfortunately, many countries had anti-vaccine groups that were affecting the vaccination campaigns badly. Those groups influenced the decision of several people on taking the vaccines and subsequently affecting the control of the disease. Changing the culture and the mentality of certain groups in societies will be the first and biggest challenges for vaccination campaigns in any pandemic in the future. Altogether, the authors hypothesized that vaccination campaigns influenced the number of confirmed and recovered cases in these Arab countries despite the impact of other related factors. It is very important to open new insights in the research of vaccine discovery and more time and effort should be spent in this area.

Recently, Hoxha and coworkers analyzed COVID-19 data from 164 different countries and concluded that higher COVID-19 vaccination rates are associated with lower COVID-19 mortality rates and that there is a tendency for more vaccinations and fewer deaths per 1,000 cases with increasing country income levels.44 Notably, Both Qatar and UAE represent as the highest income countries in the Arab world. UAE recorded the same percentage of the vaccinated population as Qatar, and both demonstrated low number of deaths. Research conducted in the United Arab Emirates regarding the inactivated BBIBP-CorV (Sinopharm) vaccine revealed that its efficacy against severe COVID-19 outcomes was 80% for hospitalization, 92% for critical care admission, and 97% for preventing death.45 In addition, a study conducted in Morocco on the long-term efficacy of the inactivated BBIBP-CorV vaccine revealed a decrease in effectiveness, dropping from 88% to 64% six months after vaccination.46 Furthermore, in Qatar, a different study demonstrated that the efficacy of BBIBP-CorV vaccine against SARS-CoV-2 infections decreased gradually, with a more rapid decline observed after the fourth month. This decline resulted in about 20% protection at five to seven months following vaccination. However, the vaccine's efficacy remained nearly 96% effective in preventing hospitalization and death six months after vaccination.47

Compared with the 15 topmost affected countries in the world, the Arab world experienced a lower number of cases and deaths PMP (Table 5). It also performed fewer tests than its population. South Korea, Japan, Argentina, Brazil, Vietnam, and India also performed a lesser number of tests than their populations. Conversely, the six European countries (France, Germany, Italy, UK, Spain, and Russia), Australia, USA, and Turkey have performed tests more than their populations. A similar result was observed for most European countries by November 2022, where the number of tests exceeded the number of residents.37 The diagnostic testing strategy and mass screening including the screening of asymptomatic people is a major strategy in controlling the spread of the virus.48 Hence, testing procedures such as PCR is a tool used to detect and record both confirmed and death cases.49 It is possible that such countries that performed fewer tests than their populations could have resulted in recording fewer confirmed cases and deaths. Furthermore, it has been suspected that the smaller number of tests carried out could be a reason for the reduced spread of the virus and the slowing down of the spread of the infection. However, the analysis conducted by Hisaka et al., (2020) concluded that extensive PCR testing might be effective in reducing the number of deaths and that further studies are required to verify this hypothesis.50

A previous study reported that older age plays a vital role in influencing the severity of COVID-19 disease and negative clinical outcomes than the younger population.51 With this, the lower deaths PMP as observed in both the Arab world (386 cases) and India (377 cases) could be attributed to the low median age of 26 and 28.7 years, respectively. By contrast, this claim contradicts why Japan with the highest median age of 48.6 years in the top 15 affected countries also recorded a low number of deaths PMP (456 cases).

Studies have reported that in response to the COVID-19 pandemic, all 44 Muslim countries including the Arab world and Turkey, mainly implemented mitigation strategies to control the virus.52,53 The main aim of implementing a mitigation strategy is to reduce the number of death tolls by focusing on the medical care of severe cases and relying on social distancing and quarantine to flatten the curve of epidemic impact and burden on hospitals.54 Stringent measures included the suspension of all airline flights, cancellation of Umrah, and down-scaling of the pilgrimage to Mecca.52 Other countries that mainly responded with mitigation strategies included the United States, and European countries.54,55 Mitigation measures are adopted immediately once the containment strategies (strict lockdowns) fail to isolate the infected individuals due to the widespread infection in the community or until vaccines are developed.56 Hence, there is a clear indication that countries vary widely in their response to the COVID-19 impact and that these differences could be partially explained by many factors such as the economic and cultural situation, governmental policies, medical capacities, the age and genetic variation between ethnic groups in a population.50

Strengths and limitations

A key strength of this study is its comprehensive follow-up and collection of COVID-19 data in each Arab country for three consecutive years. In addition, accurate monthly data were obtained from the Ministry of Health in each country and verified with the Worldometer data for COVID-19. However, there are a few limitations in our review. First, no distinction was made between Arabs and non-Arabs in the reported health data since many non-Arabs work in Arab countries. Second, COVID-19 hospitalizations are lower after being fully vaccinated, so many patients might not be included in these statistics. Third, many Arab countries lack information about COVID-19 vaccine boosters. Fourth, the lack of gender and age data in numerous Arab countries prevented us from conducting thorough comparisons and assessing potential risk factors. Finally, this study could not identify an association between COVID-19 related deaths and comorbidities due to the absence of risk factors such as hypertension, diabetes, respiratory system disease, and cardiovascular disease in the data extracted.

Conclusions

Although the number of confirmed, death, and subsequently recovered cases of COVID-19 have greatly reduced in the last quarter of 2022 in most Arab countries, further efforts to address the need to re-campaign on COVID-19 vaccines and raise awareness programs about boosters must be implemented. COVID-19 has had a relatively smaller impact on Arab countries than on other countries that have been significantly affected.

Comments on this article Comments (0)

Version 3
VERSION 3 PUBLISHED 08 Nov 2023
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Alwahaibi N, Al Maskari M, Al-Jaaidi S et al. COVID-19 in the Arab countries: Three-year review [version 2; peer review: 3 approved with reservations]. F1000Research 2024, 12:1448 (https://doi.org/10.12688/f1000research.142541.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 08 Nov 2023
Views
14
Cite
Reviewer Report 11 May 2024
Yasser Amer, King Saud University Medical City, Riyadh, Saudi Arabia 
Approved with Reservations
VIEWS 14
This study represents a comprehensive and well-conducted follow-up and collection of COVID-19 data in 22 Arab countries for three consecutive years.
The authors obtained accurate monthly data from the official websites of the Ministry of Health in each country ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Amer Y. Reviewer Report For: COVID-19 in the Arab countries: Three-year review [version 2; peer review: 3 approved with reservations]. F1000Research 2024, 12:1448 (https://doi.org/10.5256/f1000research.156102.r223543)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 26 Jun 2024
    Nasar Alwahaibi, Department of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
    26 Jun 2024
    Author Response
    We would like to express our gratitude to the reviewer for the positive feedback and valuable comments. Below are our detailed responses to the reviewer's queries.


    This study ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 26 Jun 2024
    Nasar Alwahaibi, Department of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
    26 Jun 2024
    Author Response
    We would like to express our gratitude to the reviewer for the positive feedback and valuable comments. Below are our detailed responses to the reviewer's queries.


    This study ... Continue reading
Views
9
Cite
Reviewer Report 11 May 2024
Ahmad A. Alrasheedi, Department of Family and Community Medicine, College of Medicine, Qassim University, Buraydah, Al Qassim Region, Saudi Arabia 
Approved with Reservations
VIEWS 9
Overall, this study is excellent and worth accepting as the authors evaluated the spread of the COVID-19 pandemic in a critical region, the Arab world, over three years (2020-2022). Understanding the epidemiology of COVID-19 in the Arab world and comparing ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
A. Alrasheedi A. Reviewer Report For: COVID-19 in the Arab countries: Three-year review [version 2; peer review: 3 approved with reservations]. F1000Research 2024, 12:1448 (https://doi.org/10.5256/f1000research.156102.r233650)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 26 Jun 2024
    Nasar Alwahaibi, Department of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
    26 Jun 2024
    Author Response
    We would like to extend our gratitude to the reviewer for his positive feedback and valuable comments.
    Listed below are our responses, addressing each query from the reviewer in detail.
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 26 Jun 2024
    Nasar Alwahaibi, Department of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
    26 Jun 2024
    Author Response
    We would like to extend our gratitude to the reviewer for his positive feedback and valuable comments.
    Listed below are our responses, addressing each query from the reviewer in detail.
    ... Continue reading
Views
25
Cite
Reviewer Report 01 Apr 2024
Muhammad Nauman Zahid, College of Science, University of Bahrain, Sakhir, Southern Governorate, Bahrain 
Approved with Reservations
VIEWS 25
The authors have made an interesting attempt at “COVID-19 in the Arab countries: Three-year review.” The manuscript is interesting; however, the authors need to justify the scientific writing of the manuscript. Some of the general comments are provided below:
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Zahid MN. Reviewer Report For: COVID-19 in the Arab countries: Three-year review [version 2; peer review: 3 approved with reservations]. F1000Research 2024, 12:1448 (https://doi.org/10.5256/f1000research.156102.r247533)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 09 May 2024
    Nasar Alwahaibi, Department of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
    09 May 2024
    Author Response
    We would like to take this opportunity to express our thanks to the reviewer for the positive feedback and helpful comments.

    Below are our responses, point-by-point to the queries ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 09 May 2024
    Nasar Alwahaibi, Department of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
    09 May 2024
    Author Response
    We would like to take this opportunity to express our thanks to the reviewer for the positive feedback and helpful comments.

    Below are our responses, point-by-point to the queries ... Continue reading

Comments on this article Comments (0)

Version 3
VERSION 3 PUBLISHED 08 Nov 2023
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.